Cytokinetics (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

43.03

0.19 (0.44%)

At close: May 01, 2025, 3:59 PM

38.00

-11.69%

After-hours: May 01, 2025, 04:22 PM EDT

Cytokinetics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	18.47M	7.53M	94.59M	70.43M	55.83M	26.87M	31.5M	13.37M	106.41M
Cost of Revenue	n/a	330.12M	240.81M	159.94M	96.95M	86.13M	89.14M	90.3M	59.9M
Gross Profit	18.47M	-322.59M	-146.22M	-89.51M	-41.12M	-59.26M	-57.63M	-76.93M	46.51M
Operating Income	-536.25M	-496.2M	-324.2M	-186.31M	-93.94M	-98.87M	-88.92M	-113.4M	18.69M
Interest Income	51.53M	27.63M	11.34M	331K	5.33M	4.54M	4.19M	2.6M	n/a
Pretax Income	-589.53M	-526.24M	-388.95M	-215.31M	-127.29M	-121.69M	-106.29M	-127.79M	16.45M
Net Income	-589.53M	-526.24M	-402.55M	-242.37M	-164.13M	-149.05M	-106.29M	-127.79M	16.45M
Selling & General & Admin	215.31M	173.61M	177.98M	96.8M	52.82M	39.61M	31.28M	36.47M	27.82M
Research & Development	339.41M	n/a	6.59M	159.94M	96.95M	86.13M	89.14M	90.3M	59.9M
Other Expenses	n/a	n/a	-6.59M	-159.94M	-96.95M	-86.13M	n/a	n/a	58.66M
Operating Expenses	554.72M	173.61M	177.98M	96.8M	52.82M	39.61M	31.28M	36.47M	27.82M
Interest Expense	86.51M	57.67M	51.16M	29.33M	38.68M	27.36M	21.56M	17M	2.23M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	554.72M	503.74M	418.79M	256.74M	149.77M	125.73M	120.42M	126.76M	87.72M
Income Tax Expense	n/a	n/a	13.6M	27.06M	36.84M	27.36M	4.19M	682K	-741K
Shares Outstanding (Basic)	111.98M	96.52M	89.83M	76.89M	64.52M	57.58M	54.42M	49.4M	39.94M
Shares Outstanding (Diluted)	111.98M	96.52M	89.83M	76.89M	64.52M	57.58M	54.42M	49.4M	42.56M
EPS (Basic)	-5.26	-5.45	-4.48	-3.15	-2.54	-2.59	-1.95	-2.59	0.41
EPS (Diluted)	-5.26	-5.45	-4.48	-3.15	-2.54	-2.59	-1.95	-2.59	0.39
EBITDA	-493.48M	-456.68M	-329.4M	-176.34M	-86.78M	-93.04M	-83.49M	-108.89M	14.93M
EBIT	-503.01M	-468.58M	-337.8M	-185.98M	-88.61M	-94.33M	-84.72M	-110.79M	14.19M
Depreciation & Amortization	9.53M	11.89M	8.4M	9.64M	1.83M	1.29M	1.24M	1.9M	741K